Search by Drug Name or NDC
NDC 70594-0067-01 Voriconazole 10 mg/mL Details
Voriconazole 10 mg/mL
Voriconazole is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Xellia Pharmaceuticals USA LLC. The primary component is VORICONAZOLE.
Product Information
| NDC | 70594-0067 |
|---|---|
| Product ID | 70594-067_57a39a42-1ca6-4a25-8c17-e64c3d29307a |
| Associated GPIs | |
| GCN Sequence Number | 050444 |
| GCN Sequence Number Description | voriconazole VIAL 200 MG INTRAVEN |
| HIC3 | W3B |
| HIC3 Description | ANTIFUNGAL AGENTS |
| GCN | 17499 |
| HICL Sequence Number | 023720 |
| HICL Sequence Number Description | VORICONAZOLE |
| Brand/Generic | Generic |
| Proprietary Name | Voriconazole |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Voriconazole |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/mL |
| Substance Name | VORICONAZOLE |
| Labeler Name | Xellia Pharmaceuticals USA LLC |
| Pharmaceutical Class | Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA208562 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70594-0067-01 (70594006701)
| NDC Package Code | 70594-067-01 |
|---|---|
| Billing NDC | 70594006701 |
| Package | 1 VIAL, SINGLE-USE in 1 CARTON (70594-067-01) / 20 mL in 1 VIAL, SINGLE-USE |
| Marketing Start Date | 2023-08-24 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |